Envoy Medical is trading at $0.80 (+5.44%) in pre-market, extending its recent rebound from a low of $0.76 on July 14, 2026.

  • The move appears to be continuation trading following a 12.1% gain in the previous session as technical momentum improves.
  • No new company announcements, earnings reports, FDA decisions, or analyst actions have been identified to account for the move.
  • Broader market conditions are mixed to slightly positive, providing modest support for the stock's upward trajectory.